Treatment in developing countries.
Mwinga
A
A
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003906:Developing Countries; D016503:Drug Delivery Systems; D016903:Drug Monitoring; D005102:Health Expenditures; D006801:Humans; D010349:Patient Compliance; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin